Stevanato Group (NYSE:STVN – Get Free Report) had its price objective reduced by stock analysts at KeyCorp from $37.00 to $32.00 in a report released on Thursday, Marketbeat Ratings reports. The brokerage currently has an “overweight” rating on the stock.
A number of other equities research analysts have also recently weighed in on STVN. Wall Street Zen cut Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Jefferies Financial Group set a $17.50 target price on shares of Stevanato Group in a report on Tuesday, February 10th. Morgan Stanley started coverage on shares of Stevanato Group in a report on Monday, December 1st. They issued an “equal weight” rating and a $24.00 price target on the stock. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stevanato Group in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Stevanato Group presently has an average rating of “Moderate Buy”.
Check Out Our Latest Stock Analysis on STVN
Stevanato Group Stock Down 8.5%
Institutional Trading of Stevanato Group
Large investors have recently bought and sold shares of the stock. Farther Finance Advisors LLC purchased a new position in shares of Stevanato Group in the third quarter worth $44,000. First Horizon Corp acquired a new position in shares of Stevanato Group in the 3rd quarter valued at $50,000. State of Wyoming raised its stake in Stevanato Group by 39,216.7% in the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after acquiring an additional 2,353 shares during the last quarter. GW&K Investment Management LLC lifted its position in Stevanato Group by 76.2% during the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after acquiring an additional 1,055 shares during the period. Finally, Quantbot Technologies LP purchased a new stake in Stevanato Group during the 3rd quarter valued at about $68,000.
Stevanato Group News Roundup
Here are the key news stories impacting Stevanato Group this week:
- Positive Sentiment: Company set a 2026 revenue target up to €1.308 billion and expects high‑value solutions to reach ~48% of sales — a shift toward higher‑margin products that supports revenue growth and margin expansion. Stevanato Group outlines 2026 revenue target up to €1.308B with high-value solutions set to reach 48% of sales
- Positive Sentiment: Full‑year 2025 revenue grew 7% (9% at constant currency) with record revenue from high‑value solutions and expanded margins — evidence that the product mix transition is already contributing to results. Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025
- Positive Sentiment: Market reaction was strong after the quarter — reports show the stock surged following the Q4 release as investors rewarded top‑line growth and the high‑value narrative. Stevanato Group surges nearly 17% on fourth quarter earnings beat
- Neutral Sentiment: Management commentary from the Q4 2025 earnings call provides execution detail on capacity, product mix and margin levers; useful for judging whether targets are achievable but contains typical quarterly nuance rather than new catalysts. Stevanato Group S.p.A. (STVN) Q4 2025 Earnings Call Transcript
- Neutral Sentiment: Analyst/press pieces are urging investors to reassess valuation after the rebound — the stock trades with a relatively high P/E and a mix shift that could justify a premium, but valuation risk remains. Is It Time To Reassess Stevanato Group (STVN) After The Recent Share Price Rebound
- Negative Sentiment: EPS figures were reported inconsistently across outlets (some data sources show a small miss vs one consensus figure, while others report a beat), creating short‑term confusion; additionally FY2026 EPS guidance (0.690–0.730) sits at or slightly below some consensus estimates — a modest downside risk if execution slips. Stevanato Group earnings report on MarketBeat Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates
About Stevanato Group
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Read More
- Five stocks we like better than Stevanato Group
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
